These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2341493)

  • 1. Effect of ciprofloxacin on the pharmacokinetics of antipyrine in healthy volunteers.
    Tan KK; Allwood MC; Shawket S
    J Clin Pharm Ther; 1990 Apr; 15(2):151-4. PubMed ID: 2341493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
    Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ciprofloxacin on antipyrine metabolism.
    Ludwig E; Székely E; Csiba A; Graber H
    J Antimicrob Chemother; 1988 Jul; 22(1):61-7. PubMed ID: 3170391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of antipyrine in African patients with Hodgkin's lymphoma.
    Juma FD
    Br J Clin Pharmacol; 1987 Dec; 24(6):809-11. PubMed ID: 3440100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers.
    Nayak VK; Kshirsagar NA; Desai NK; Satoskar RS
    Br J Clin Pharmacol; 1988 Nov; 26(5):604-6. PubMed ID: 3207565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic interactions of ciprofloxacin.
    Ludwig E; Graber H; Székely E; Csiba A
    Diagn Microbiol Infect Dis; 1990; 13(2):135-41. PubMed ID: 2369810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
    Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
    J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effects on antipyrine pharmacokinetics.
    Knudsen JB; Bastain W; Sefton CM; Allen JG; Dickinson JP
    Xenobiotica; 1992 May; 22(5):579-89. PubMed ID: 1413873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study to evaluate the effect of a course of ranitidine on antipyrine kinetics.
    Dawson P; Clarke J
    J Clin Pharm Ther; 1987 Feb; 12(1):65-7. PubMed ID: 3449565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine pharmacokinetics in women receiving conjugated estrogens.
    Scavone JM; Greenblatt DJ; Blyden GT
    J Clin Pharmacol; 1988 May; 28(5):463-6. PubMed ID: 3392245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
    Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
    Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of subject age on the inhibition of oxidative metabolism by ciprofloxacin.
    Waite NM; Rybak MJ; Krakovsky DJ; Steinberg JD; Warbasse LH; Edwards DJ
    Antimicrob Agents Chemother; 1991 Jan; 35(1):130-4. PubMed ID: 2014968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of oral contraceptive use and cigarette smoking, alone and together, on antipyrine pharmacokinetics.
    Scavone JM; Greenblatt DJ; Abernethy DR; Luna BG; Harmatz JS; Shader RI
    J Clin Pharmacol; 1997 May; 37(5):437-41. PubMed ID: 9156376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nifedipine on antipyrine and theophylline disposition.
    Adebayo GI; Mabadeje AF
    Biopharm Drug Dispos; 1990 Mar; 11(2):157-64. PubMed ID: 2183884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.
    Anadón A; Martinez-Larrañaga MR; Díaz MJ; Bringas P; Fernandez MC
    Arch Toxicol; 1991; 65(2):156-9. PubMed ID: 2059156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine does not alter antipyrine metabolism.
    Bowles SK; Cardozo L; Edwards DJ
    J Clin Pharmacol; 1990 Mar; 30(3):267-71. PubMed ID: 2312782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.
    Yang BB; Hounslow NJ; Sedman AJ; Forgue ST
    J Clin Pharmacol; 1996 Apr; 36(4):356-60. PubMed ID: 8728350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.